They found that, in both in vitro and in vivo models of AD, chrysin can downregulate the early growth response (EGR1) expression in HaCaT cells, leading to a downregulation of TNA-alpha and consequent lowering of TSLP production. The gene discussed is TSLP; the disease is Alzheimer disease.